Cambridge Heart is committed to reducing the impact of Sudden Cardiac Arrest (SCA) by developing ways to non-invasively identify individuals at risk of life-threatening arrhythmias.  The average out-of-hospital survival rate for SCA is only 5%, making prediction and prevention critically important.

Microvolt T-Wave Alternans™ (MTWA) is a clinically-proven, non-invasive diagnostic test that allows physicians to determine which of their patients are at highest – and lowest – risk of experiencing SCA. 

Cambridge Heart is proud to offer the HearTwave® II Stress Testing System, the only stress test system on the market with a reimbursable MTWA option.